IL-2, the first cytokine that is a potential therapeutic target for the modulation of immune responses, boosts the immune response in cancer and autoimmune diseases and promotes the generation of Treg cells, B cell proliferation, the secretion of antibodies and macrophage activation. Here, IL2 is linked to cancer.